Efficacy of N-acetylcysteine on neuroclinical, biochemical, and histopathological parameters in experimental spinal cord trauma: comparison with methylprednisolone

European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society
U Y ÇavuşI Ağır

Abstract

N-acetylcysteine (NAC) is an antioxidant agent that has been shown to have beneficial effects when treating various diseases. The aim of this study was to investigate the effects of NAC on spinal cord injury in an experimental rat model. A total of 48 adult male wistar albino rats were divided into six groups. Group C included the control rats, group L included the rats that underwent laminectomy, and group T included the rats in which spinal cord trauma was induced by the weight-drop method after laminectomy. Groups M (the methylprednisolone group), N (the NAC group), and MN (the methylprednisolone + NAC group) were the treatment groups. In the fourth group (group M), 30 mg/kg methylprednisolone (MP) was administered as a bolus intraperitoneally (IP), and a standard MP treatmentat a dose of 5.4 mg/kg was applied for 24 h. In the fifth group (group N), only 300 mg/kg NAC was administered as a bolus IP. In the sixth group (group MN), the standard MP treatment and a single 300 mg/kg dose of NAC were administered as a bolus IP. The motor functions of the rats were evaluated on the 1st, 7th, and 14th days using the inclined plane test defined by Rivlin and Tator and the motor scale defined by Gale et al. Spinal cord samples were ob...Continue Reading

References

Jan 1, 1990·Methods in Enzymology·H Esterbauer, K H Cheeseman
Jun 26, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A RahmanF S Erol
Oct 5, 2001·Clinical Neuropharmacology·R J DumontA S Dumont
Jul 20, 2002·Spine·Brian K KwonWolfram Tetzlaff
Mar 6, 2003·The Anatomical Record. Part B, the New Anatomist·H Louis HarkeyDuane E Haines
Sep 6, 2003·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·Omer CakirNesimi Eren
Mar 30, 2005·Annals of Emergency Medicine·Laurie Prescott
Oct 27, 2005·Intensive Care Medicine·Ulrich-Wilhelm ThomaleJohn F Stover
Dec 20, 2005·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·M BogaI Meteoglu
Jun 8, 2006·Neurochemical Research·Tufan HicdonmezSebahattin Cobanoglu
Aug 23, 2007·ILAR Journal·Stephen M OniferStephen W Scheff
Sep 14, 2007·The Cerebellum·Motoki Arakawa, Yoshihisa Ito
Mar 21, 2008·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Kee-Yong HaSoon-Eok Kwon
Mar 23, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Edward D Hall
May 25, 2011·Pharmacology & Therapeutics·Alexander G RabchevskyJoe E Springer
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Michael B Bracken
Sep 12, 2012·Neurocritical Care·Deborah M SteinScott D Weingart
Feb 26, 2013·The Journal of Spinal Cord Medicine·UNKNOWN National Spinal Cord Injury Statistical Center
Jul 17, 2013·Neurosurgery·Beverly C WaltersUNKNOWN Congress of Neurological Surgeons

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.